Ingevity director awarded 1,904 restricted shares
Lynch Frederick J reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Lynch Frederick J reported acquisition or exercise transactions in this Form 4 filing.
Ingevity Corp director Frederick J. Lynch reported a compensation-related equity award. He received 1,904 restricted stock units of Ingevity common stock at no purchase price under the company’s 2025 Omnibus Incentive Plan. These units will vest in full on April 30, 2027, bringing his direct holdings to 28,263 shares after the grant.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,904 | $0.00 | $0.00 |
Footnotes (1)
- F1. Grant of restricted stock units pursuant to Ingevity Corporation's 2025 Omnibus Incentive Plan, which will vest in full on April 30, 2027.
Key Figures
Key Terms
restricted stock units financial
2025 Omnibus Incentive Plan financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Frederick J. Lynch report in his latest Form 4 for Ingevity (NGVT)?
How many restricted stock units did Frederick J. Lynch receive from Ingevity (NGVT)?
When do Frederick J. Lynch’s Ingevity (NGVT) restricted stock units vest?
Was Frederick J. Lynch’s Ingevity (NGVT) equity award an open-market stock purchase?
Under which plan were Frederick J. Lynch’s Ingevity (NGVT) restricted stock units granted?
AI-generated analysis. How Rhea-AI works. Not financial advice.